AT1 - Atomo Diagnostics

Remove this Banner Ad

ash_1050

Premiership Player
Nov 21, 2009
4,428
8,563
Melbourne
AFL Club
Essendon
Other Teams
Melbourne Victory and Arsenal
After their belter of a day today (+14.71%) I figured now is as good a time as any to create an AT1 thread.

AT1 primarily produced rapid HIV testing kits, however they've recently pivoted with COVID19 causing havoc and are now ramping up production to churn out as many kits as they can.
AT1 have partnered with French biotech company NG Biotech who produce the covid detection strip, while AT1 supply the testing kit.
As long as Covid kicks on I think there's a huge amount of potential with the company.
Currently holding a stack at $0.42 and have a price prediction of $0.80 by end of 2020.
Let's see how that prediction goes.
 

ash_1050

Premiership Player
Nov 21, 2009
4,428
8,563
Melbourne
AFL Club
Essendon
Other Teams
Melbourne Victory and Arsenal
FY19 results to be released on Monday 31st August. Share price has jumped up the last couple of days as it will be good news.
 

Log in to remove this ad.

ash_1050

Premiership Player
Nov 21, 2009
4,428
8,563
Melbourne
AFL Club
Essendon
Other Teams
Melbourne Victory and Arsenal
Well it took 14 months but my prediction is finally starting to pay off, AT1 doing very well with their rapid testing kits and their share price is picking up some serious steam.

Shame I sold out 8 months ago.
 
Aug 14, 2011
44,794
16,853
Trafalgar
AFL Club
West Coast
Other Teams
Mclaren Mercedes F1
Aug 14, 2011
44,794
16,853
Trafalgar
AFL Club
West Coast
Other Teams
Mclaren Mercedes F1
The Aus is running with it:

The boss of one of Australia’s leading rapid test makers has a simple message for public health authorities.
You need to start planning for more rapid testing now.

John Kelly, the chief executive of ASX-listed medtech Atomo Diagnostics, says Australia needs to catch up with the rest of the world – particularly Europe – when it comes to widespread use of rapid testing and accept that it can play an important role in the Covid healthcare response.
“If the current situation doesn’t make that clear – I’m not sure what would. Rapid testing is one of the key pillars of Covid response,” he says.

“There’s no national rapid test strategy and we’ve been waiting two years for this to happen. I don’t understand why as a nation we are not better prepared,” he says.

Atomo, which develops and commercialises antigen-based tests, has been leading the charge in Australia for wider take-up of rapid tests by government to ease the pressure on the lab-based PCR testing. But talks have so far generated little interest.

At times Atomo has found itself wedged between Canberra and the state governments both saying the other is responsible for pushing rapid tests, leaving Australia with one of the lowest adoption rates in the developed world.
 

Remove this Banner Ad

Back